The S&P Pharma Dose - Episode 31: Thoughts On Pharma’s Washington Grilling | S&P Global Ratings

Name: The S&P Pharma Dose - Episode 31: Thoughts On Pharma’s Washington Grilling
Uploaded: 2019-06-03T21:02:49.000Z
Duration: T12M7S
Description: S&P Global’s pharmaceutical themed podcast show returns with some quick thoughts on the pharma industry’s testimony at a congressional hearing on Capitol Hill. A comprehensive list of challenges/criticisms of the industry, but where were the suggested solutions? Noise level on pharma pricing is only going to increase as we near presidential election.

In This List

The S&P Pharma Dose - Episode 31: Thoughts On Pharma’s Washington Grilling

COMMENTS

Select: Global Pharmaceutical Companies Ratings Are Unlikely To Be Highly Disrupted By Rising Risks

COMMENTS

Credit FAQ: Retailers' Cyber Attack Recovery Is Slowed By Logistical Scale And Complexity

COMMENTS

Default, Transition, and Recovery: The U.S. Leveraged Loan Default Rate Could Rise To 1.75% Through March 2026

COMMENTS

Instant Insights: Key Takeaways From Our Research

7 Mar, 2019 | 12:00

Listen: The S&P Pharma Dose - Episode 31: Thoughts On Pharma’s Washington Grilling

Sector Corporates

S&P Global’s pharmaceutical themed podcast show returns with some quick thoughts on the pharma industry’s testimony at a congressional hearing on Capitol Hill. A comprehensive list of challenges/criticisms of the industry, but where were the suggested solutions? Noise level on pharma pricing is only going to increase as we near presidential election.

Sector
Corporates

Create a free account to unlock the article.

Gain access to exclusive research, events and more.

Already have an account? Sign in